Stay updated on Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial

Sign up to get notified when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    - Footer revision updated from v3.4.0 to v3.4.1; a minor maintenance change that does not affect study details.
    Difference
    0.0%
    Check dated 2026-02-04T04:54:28.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A 'Show glossary' option was added to the page. Revision information was updated to v3.4.0, replacing v3.3.4 and updating capitalization of related labels.
    Difference
    0.2%
    Check dated 2026-01-28T03:16:36.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4. No visible changes to study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-01-14T01:34:26.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a consolidated Locations section with state-level site listings (California, Illinois, Kansas, Massachusetts, Michigan, Missouri, New York, Texas, Wisconsin) and updated the page revision from v3.3.2 to v3.3.3. The old per-state location headings were removed.
    Difference
    1.0%
    Check dated 2025-12-23T13:45:31.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Site revision updated from v3.2.0 to v3.3.2 (v3.3.2 added, v3.2.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T17:49:39.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A government funding/operating status notice was removed from the page. This change affects only contextual messaging and does not alter the study details or eligibility information.
    Difference
    0.3%
    Check dated 2025-11-17T17:45:58.000Z thumbnail image

Stay in the know with updates to Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.